Trials / Recruiting
RecruitingNCT06412237
An Exploratory Study of a Wearable Robotic Hand Orthosis
An Exploratory Study of a Wearable Robotic Hand Orthosis in the Chronic Stroke Population in Singapore: A Clinic to Home Feasibility Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Tan Tock Seng Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Upper limb deficits usually remain in 75% of the stroke survivors despite completing full rehabilitation. This is due to lack of effectiveness of rehabilitation and the degree of support and resources available. In this study, the investigators plan to study the use of assistive technologies in chronic stroke survivors.
Detailed description
Assistive technologies have shown promising results in immediate improvement in functional abilities. RELab tenoexo is a fully wearable and portable robotic hand orthoses (RHO) used for functional training. Its design support end users with functional hand opening and closing and can be applied in therapy exercises or during functional activities. While prior research demonstrated its effectiveness for spinal cord injury, it hasn't been tailored for multi-ethnic stroke populations. This study aims to determine the feasibility and extent to which the RELab tenoexo can complement therapy training in clinic and further be used as both a training and assistive device in the home environment. In addition, it also aims to investigate the amount of upper limb usage before, during and after the training period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RELab tenoexo | The RELab tenoexo is a fully wearable and portable RHO developed at the Rehabilitation Engineering Laboratory (RELab) at ETH Zurich. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2024-05-14
- Last updated
- 2025-04-15
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT06412237. Inclusion in this directory is not an endorsement.